
PetMed Express, Inc.: updates and filings
Price
$0.90
November 17, 2026Market cap $19M
What Ploutos Investor adds for PetMed Express
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from FY2010
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has fallen 26% since Nov 10, 2026, when the 10-Q these figures come from was filed ($1.21 then, $0.90 on Nov 17, 2026). The figures date from before that move.10-Q
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 10, 2026next Feb 11, 2027
A rough estimate from when it has reported before, which has varied. The company announces the date itself.
November 2026
September 2026
August 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 12, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 10, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 10, 2026Results of operationsForm8-K
- Sep 28, 2026Shares registered for employeesFormS-8
- Sep 28, 2026Shares registered for employeesFormS-8
- Sep 28, 2026Officer or director changeForm8-K
- Sep 21, 2026Officer or director change, Regulation FD disclosureForm8-K
- Sep 17, 2026Officer or director change, Regulation FD disclosureForm8-K
- Aug 13, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 13, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 13, 2026Results of operationsForm8-K
- Aug 12, 2026Officer or director change, shareholder voteForm8-K
- Jul 23, 2026Material agreement entered, Regulation FD disclosureForm8-K
- Jun 29, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Jun 26, 2026Officer or director changeForm8-K
- Jun 25, 2026Additional annual meeting materialFormDEFA14A
- Jun 25, 2026Annual meeting proxy statementFormDEF 14A
- Jun 2, 2026Annual reportfor the period to Mar 31, 2026Form10-K
- Jun 2, 2026Results of operationsForm8-K
- May 21, 2026Material eventForm8-K
- Feb 11, 2026Over-5% holder statement (active)FormSCHEDULE 13D
- Feb 5, 2026Quarterly reportfor the period to Dec 31, 2025Form10-Q
- Jan 23, 2026Shareholder voteForm8-K
- Dec 29, 2025Change of auditor (amendment)Form8-K/A
- Dec 19, 2025Quarterly reportfor the period to Sep 30, 2025Form10-Q
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 12, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 10, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 10, 2026 | 8-K | Results of operations | Document |
| Sep 28, 2026 | S-8 | Shares registered for employees | Document |
| Sep 28, 2026 | S-8 | Shares registered for employees | Document |
| Sep 28, 2026 | 8-K | Officer or director change | Document |
| Sep 21, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Sep 17, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Aug 13, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 13, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 13, 2026 | 8-K | Results of operations | Document |
| Aug 12, 2026 | 8-K | Officer or director change, shareholder vote | Document |
| Jul 23, 2026 | 8-K | Material agreement entered, Regulation FD disclosure | Document |
| Jun 29, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Jun 26, 2026 | 8-K | Officer or director change | Document |
| Jun 25, 2026 | DEFA14A | Additional annual meeting material | Document |
| Jun 25, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Jun 2, 2026 | 10-K | Annual reportfor the period to Mar 31, 2026 | Document |
| Jun 2, 2026 | 8-K | Results of operations | Document |
| May 21, 2026 | 8-K | Material event | Document |
| Feb 11, 2026 | SCHEDULE 13D | Over-5% holder statement (active) | Document |
| Feb 5, 2026 | 10-Q | Quarterly reportfor the period to Dec 31, 2025 | Document |
| Jan 23, 2026 | 8-K | Shareholder vote | Document |
| Dec 29, 2025 | 8-K/A | Change of auditor (amendment) | Document |
| Dec 19, 2025 | 10-Q | Quarterly reportfor the period to Sep 30, 2025 | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Jan 10, 2000.
The full analysis
What do PetMed Express's filings show?
The filings are where every one of PetMed Express's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.